Fig. 4

The distribution of C. psittaci or COVID-19 pneumonia was described according to (A) lesions in bilateral lungs, (B) ground-glass opacity, (C) nervous system symptoms, (D) lymphocyte percentage, (E) creatine kinase at admission.
The distribution of C. psittaci or COVID-19 pneumonia was described according to (A) lesions in bilateral lungs, (B) ground-glass opacity, (C) nervous system symptoms, (D) lymphocyte percentage, (E) creatine kinase at admission.